Objective evaluation of lens clarity after the intravitreal injection of sustained-release dexamethasone implant


Anayol M. A., ŞEKEROĞLU M. A., Tirhis H., Gulpamuk B., DOĞUİZİ S., Yilmazbas P.

Journal of Cataract and Refractive Surgery, cilt.42, sa.10, ss.1477-1482, 2016 (SCI-Expanded, Scopus)

  • Yayın Türü: Makale / Özet
  • Cilt numarası: 42 Sayı: 10
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.jcrs.2016.08.018
  • Dergi Adı: Journal of Cataract and Refractive Surgery
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.1477-1482
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Purpose To evaluate the lens densitometry values in eyes with macular edema secondary to retinal vein occlusion that were treated with intravitreal dexamethasone implants and to compare these data with those of fellow healthy control eyes. Setting Ulucanlar Eye Training and Research Hospital, Ankara, Turkey. Design Prospective case series. Methods Patients with unilateral macular edema secondary to retinal vein occlusion who were to be treated with intravitreal dexamethasone implants were recruited. The lens densitometry values measured with Scheimpflug imaging before and 3 months after the injection were compared with those in fellow healthy eyes. Results Thirty-seven patients (22 with branch retinal vein occlusion and 15 with central retinal vein occlusion) with a mean age of 61.5 years ± 11.4 (SD) (range 37 to 82 years) were included. The mean lens densitometry value at Pentacam densitometry zone 1 was significantly increased in the study eyes at 3 months compared with baseline values (baseline 9.44 ± 0.99; 3 months 9.68 ± 1.24; P = .015). At zones 2 and 3, the mean and maximum lens densitometry values in study eyes and lens thickness were similar at baseline and 3 months after injection (P > .05). The densitometry values in fellow healthy eyes were also similar at baseline and at 3 months. Conclusion The mean lens densitometry value at zone 1 significantly increased from baseline in the study eyes 3 months after the injection of the dexamethasone implant for the treatment of macular edema secondary to retinal vein occlusion. Financial Disclosure None of the authors has a financial or proprietary interest in any material or method mentioned.